- About Us
-
Medicines under development
- SB-REG-KMAS – stem cells in the treatment of mastitis in cows
- SB-REG-CORTO – innovative cell therapy for osteoarthritis in dogs
- SB-REG-HORTO – stem cell therapy for horses
- SB-REG-CSKIN – cell therapy for dogs and cats with atopic dermatitis
- SB-REG-FKIDNEY – cell therapy for kidneys
- SB-REG-CDM – stem cell therapy in canine neurology
- SB-REG-HMILA – ILA-1 biological therapy for horses and dogs
- Therapies
- Treatment of animals
- Our R&D
- Contact
- Home
- > weterynaria
- > Horses: an overview of therapies
Regenerative therapies for horses
– stem cells, PRP, and ILA-1
A modern approach to treating sport and recreational horses
Orthopedic injuries, joint degeneration, and chronic inflammation are among the most common health problems in horses. Modern veterinary medicine is increasingly turning to biological therapies—mesenchymal stem cells (MSCs), platelet-rich plasma (PRP), and ILA-1 protein—which support the body's natural regenerative processes and avoid long-term pharmacological treatment.
Range of therapies for horses – quick link to subpages
― Osteoarthritis in horses (osteoarthrosis)
― Tendon and ligament injuries in horses – PRP and MSC
― Articular cartilage damage in horses
― Chronic wounds and ulcers in horses
― Hot spots (skin inflammation) in horses
How it works
- MSC (Mesenchymal Stem Cells) – differentiate into chondrocytes and osteoblasts, support tissue regeneration, modulate the immune response, and reduce inflammation.
- PRP (Platelet-Rich Plasma) – source of growth factors that stimulate the regeneration of soft and bone tissue
- ILA-1 (Interleukin-1 Receptor Antagonist) – naturalny inhibitor interleukiny-1, blokujący kaskadę zapalną i zmniejszający ból stawowy.
Clinical benefits:
- faster return of the horse to training,
- lower risk of injury recurrence,
- reduction of pain and inflammation,
- no side effects typical of steroids,
- improvement in athletic performance and quality of life of the horse.
Scientific publications confirming effectiveness
Research conducted by the Sanford Biotech team and partner centers (Lublin University of Life Sciences, UWM, University of Maryland, Polish Academy of Sciences) confirms the effectiveness of MSC and PRP therapies in large animals.